Addressing the epidemic of antibiotic "allergy" over-diagnosis

Ann Allergy Asthma Immunol. 2020 Jun;124(6):550-557. doi: 10.1016/j.anai.2019.12.016. Epub 2019 Dec 24.

Abstract

Objective: An epidemic of antibiotic allergy is occurring.

Data sources: Articles published since 2008.

Study selections: Articles on antibiotic allergy and stewardship.

Results: A number of overlapping factors contribute. The most important factor is antibiotic overuse. Antibiotics are commonly used in situations in which no antibiotics are indicated. Thirty percent to 50% of ambulatory antibiotic use may be inappropriate. The duration of indicated antibiotic use is often excessive, which leads to more side effects. All antibiotic use can result in adverse reactions, and a fraction of these will be dutifully recorded as an allergy in the electronic health record (EHR). Most EHRs are not well structured to accurately convey information on expected side effects that have occurred, metabolic or other contraindications, dose-related or situational toxicities, personal preferences, clinically significant immunologically mediated hypersensitivity, and other reasons a particular patient may not want or should not be given a specific drug or type of drug in the future. As populations age, their accumulated baggage of reported antibiotic allergies increase. Suspected antibiotic allergy is rarely confirmed with appropriate testing or rechallenge. Patients then receive suboptimal antibiotic therapy and experience more side effects, treatment failures, and serious antibiotic-resistant infections. Reporting an antibiotic allergy in the EHR is nominally done to improve patient safety, but unfortunately, this is often not the actual result.

Conclusion: Audit and feedback, to help ensure adherence to Choosing Wisely recommendations and good antibiotic stewardship practices, can help reduce inappropriate antibiotic use. Restructuring EHRs to facilitate correct drug intolerance reporting, along with active antibiotic allergy delabeling programs, can help stem this epidemic.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / adverse effects*
  • Clinical Decision-Making
  • Comorbidity
  • Drug Hypersensitivity / diagnosis
  • Drug Hypersensitivity / epidemiology*
  • Drug Hypersensitivity / immunology*
  • Drug Hypersensitivity / prevention & control
  • Electronic Health Records
  • Female
  • Humans
  • Male
  • Medical Overuse* / statistics & numerical data
  • Public Health Surveillance
  • Skin Tests

Substances

  • Anti-Bacterial Agents